Variant · Snv
TAF2 NM_003184.4(TAF2):c.654C>T (p.Gly218=)
CI-VAR-00235681Explore in graph →p.Gly218=NM_003184.4:c.654C>TClinVar 1557481 rs61753749
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1557481 | Benign | criteria provided, multiple submitters, no conflicts | 2 | TAF2-related disorder; Uterine corpus endometrial carcinoma; Malignant lymphoma, large B-cell, diffuse; Colon adenocarcinoma; Colorectal cancer; Ovarian serous cystadenocarcinoma; Thyroid cancer, nonmedullary, 1; Cervical cancer; Melanoma; Acute myeloid leukemia; Malignant tumor of esophagus; Lung cancer; Sarcoma; Uterine carcinosarcoma | germline | 4 | Jun 01, 2026 | clinvar |